chikungunya
fever
spread
sever
indian
ocean
island
india
includ
popular
travel
destin
compar
use
diagnost
test
understand
reason
magnitud
sever
outbreak
use
diagnost
method
test
sampl
patient
return
europ
indian
ocean
region
chikungunya
infect
confi
rmed
patient
fi
rst
half
year
second
half
revers
transcriptionpcr
posit
sampl
taken
day
symptom
onset
immunofl
uoresc
detect
immunoglobulin
ig
day
igg
day
patient
patient
day
onward
soon
onset
symptom
patient
igg
igm
high
viral
load
copiesml
plasma
data
help
healthcar
provid
select
diagnost
test
return
travel
n
outbreak
chikungunya
fever
unpreced
magnitud
spread
western
indian
ocean
region
includ
comoro
island
mauritiu
island
madagascar
seychel
octob
island
alon
popul
least
case
report
epidem
swept
eastward
indian
subcontin
end
year
caus
million
case
attack
rate
region
begin
epidem
declin
la
seychel
seem
continu
area
india
new
outbreak
report
earli
malaysia
mid
indonesia
chikungunya
viru
chikv
arthropodborn
rna
viru
genu
alphaviru
famili
togavirida
genom
singl
strand
posit
polar
kb
long
base
partial
sequenc
envelop
protein
chikv
strain
group
distinct
genet
lineag
share
common
ancestor
tropic
africa
viru
transmit
human
numer
aed
mosquito
speci
includ
ae
aegypti
ae
albopictu
latter
thought
less
compet
vector
strict
mosquitocontrol
measur
amelior
outbreak
indian
ocean
island
spread
strain
chikv
india
prove
viru
easi
contain
tourist
visit
region
import
viru
back
europ
unit
state
includ
region
countri
vector
known
present
chikv
infect
human
character
sudden
onset
fever
rash
sever
arthralgia
specifi
c
treatment
exist
symptom
gener
selflimit
popular
tourist
destin
indian
ocean
region
diseas
endem
along
malaria
dengu
chikv
test
conduct
outpati
set
antibodi
assay
viru
isol
revers
transcriptionpcr
rtpcr
avail
clinic
manag
chikungunya
know
laboratori
assay
provid
inform
given
point
time
diseas
help
crosssect
detect
rate
kinet
virolog
paramet
time
viru
rna
immunoglobulin
ig
igg
crucial
unfortun
data
chikv
minim
studi
larg
patient
cohort
complet
relev
laboratori
test
particularli
rtpcr
becam
avail
recent
studi
use
method
number
studi
patient
limit
provid
support
select
diagnost
test
collect
cumul
fi
gure
virolog
paramet
viral
rna
detect
antibodi
test
result
time
largest
cohort
return
travel
studi
date
addit
sought
possibl
reason
magnitud
sever
current
outbreak
relev
recent
fi
nding
indian
ocean
chikv
strain
display
genet
characterist
structur
gene
especi
amino
acid
posit
similar
relat
semliki
forest
viru
homolog
mutat
caus
enhanc
membran
fusion
capac
insect
cell
viru
could
advantag
insect
even
human
determin
whether
mutat
infl
uenc
viral
load
patient
cohort
distribut
geograph
tempor
januari
decemb
test
sampl
patient
bernhardnocht
institut
tropic
medicin
hamburg
germani
chikv
infect
symptom
compat
acut
recent
chikv
infect
sudden
onset
fever
muscl
joint
pain
headach
rash
upon
return
europ
germani
n
belgium
n
switzerland
n
denmark
n
poland
n
patient
exact
travel
destin
report
madagascar
n
mauritiu
n
seychel
n
island
n
bali
n
indonesia
n
sri
lanka
n
india
n
malaysia
n
kenya
n
thailand
n
averag
age
travel
countri
differ
signifi
cantli
analysi
varianc
ftest
p
patient
exact
date
onset
sampl
could
retriev
voluntari
questionnair
complet
telephon
fax
issuanc
result
age
sex
distribut
travel
histori
patient
shown
tabl
day
onset
symptom
defi
ned
day
sampl
possibl
chikv
test
igg
igm
indirect
immunofl
uoresc
fi
rst
half
sampl
test
realtim
rtpcr
addit
howev
second
half
year
rtpcr
test
restrict
sampl
patient
acut
infect
basi
experi
fi
rst
month
describ
classifi
cation
patient
laboratoryconfi
rmed
case
requir
either
posit
rtpcr
igm
result
isol
igg
detect
least
subsequ
increas
titer
statgraph
plu
softwar
packag
manugist
dresden
germani
use
statist
analys
chikv
strain
grown
vero
cell
multipl
infect
cell
spread
slide
h
air
dri
fi
xed
icecold
aceton
serum
sampl
incub
h
igg
overnight
igm
fi
xed
cell
antibodi
detect
antihuman
igg
igm
label
fl
uorescein
isothiocyan
sifi
n
berlin
germani
igm
test
igg
absorb
test
biosorb
resin
biom
munich
germani
specifi
citi
antibodi
confi
rmed
plaquereduct
neutral
assay
select
sampl
data
shown
two
version
realtim
rtpcr
target
gene
chikv
use
chikv
gener
adapt
specifi
calli
current
epidem
strain
reaction
condit
oligonucleotid
list
tabl
quantifi
ed
vitrotranscrib
rna
gener
clone
rtpcr
target
region
plasmid
invitrogen
karlsruh
germani
insert
togeth
promotor
sequenc
amplifi
ed
plasmidspecifi
c
primer
transcrib
rna
use
megascript
reagent
ambion
austin
tx
usa
dnase
digest
affi
niti
purifi
cation
transcript
quantifi
ed
photomet
use
quantifi
cation
standard
competit
intern
control
gener
overlapextens
pcr
describ
use
chik
chika
primer
mutagen
primer
mutat
construct
clone
transcrib
rna
assay
crossreact
rna
extract
serum
sampl
high
titer
undilut
cell
cultur
supernat
follow
virus
barmah
forest
dengu
epsteinbarr
hepat
c
herp
simplex
type
human
immunodefi
cienci
type
japanes
enceph
poliomyel
type
ross
river
sindbi
venezuelan
equin
encephalt
west
nile
yellow
fever
accord
seri
parallel
limitingdilut
experi
fragment
chikv
gene
posit
genbank
access
amplifi
ed
directli
patient
plasma
sequenc
sequenc
perform
ceq
genet
analysi
system
beckman
coulter
krefi
eld
germani
recommend
sequenc
analyz
lasergen
softwar
packag
dnastar
madison
wi
usa
serum
sampl
test
dengu
antibodi
igm
assay
panbio
sinnamon
park
queensland
australia
indirect
igg
immunofl
uoresc
assay
describ
sampl
reportedli
taken
fi
rst
day
ill
also
test
dengu
viru
realtim
rtpcr
chikv
infect
laboratoryconfi
rmed
symptomat
patient
sampl
median
igg
titer
iggposit
sampl
rang
median
igm
titer
igmposit
sampl
rang
median
viral
load
rna
posit
sampl
rna
copiesml
rang
rna
copiesml
tabl
summar
crosssect
test
result
individu
patient
time
fi
rst
visit
fi
rst
half
year
rate
confi
rmed
infect
patient
suspect
chikv
second
half
although
number
laboratori
test
compar
fi
rst
second
half
year
vs
laboratori
confi
rmation
rate
travel
signifi
cantli
higher
fi
rst
half
test
p
abl
retriev
sampl
exact
inform
travel
destin
onset
symptom
date
sampl
patient
figur
chikv
igg
found
patient
sampl
earliest
sampl
detect
igg
titer
drawn
day
onset
latest
day
isol
igg
titer
ie
concomit
igm
detect
sampl
collect
late
onset
median
day
rang
day
remain
sampl
collect
day
posit
rtpcr
demonstr
chikv
igm
found
sampl
patient
earliest
igmposit
result
obtain
sampl
drawn
day
latest
obtain
day
sampl
igm
sampl
concomit
igg
titer
drawn
day
onset
fever
concomitantli
posit
rtpcr
patient
whose
fi
rst
sampl
yield
antibodi
consecut
sampl
avail
pair
sampl
drawn
least
day
apart
fi
rst
sampl
collect
median
day
onset
rang
day
igm
median
titer
igg
median
titer
second
sampl
collect
median
day
onset
rang
day
median
igg
titer
median
igm
titer
patient
igm
detect
second
serum
sampl
earliest
drawn
day
onset
symptom
patient
complet
histori
posit
realtim
rtpcr
result
compar
effi
cienci
diagnost
method
acut
diseas
select
sampl
collect
fi
rst
day
symptom
patient
chikv
confi
rmed
viru
isol
subsequ
seroconvers
n
rtpcr
posit
day
regardless
antibodi
result
figur
igg
igm
posit
day
onward
igm
detect
day
earlier
igg
overlap
rtpcr
antibodi
result
occur
day
posit
rtpcr
result
found
day
assess
whether
chikv
rna
detect
may
infl
uenc
antivir
antibodi
compar
rna
concentr
seroneg
n
seroposit
n
sampl
collect
within
fi
rst
day
ill
figur
median
rna
concentr
copi
ml
seroneg
sampl
signifi
cantli
higher
copiesml
found
median
concentr
seroposit
sampl
p
analysi
varianc
ftest
character
cours
viremia
absenc
antibodi
plot
viral
load
antibodyneg
pcrposit
sampl
sampl
day
highest
concentr
found
sampl
drawn
day
mean
rna
copiesml
ci
copiesml
figur
viral
load
later
sampl
continu
decreas
reassess
diagnost
valu
classic
viru
isol
techniqu
cultur
pcrposit
serum
sampl
vero
cell
materi
frozen
thaw
time
cell
cultur
sampl
yield
viru
isol
viru
isol
sampl
contain
rna
copiesml
figur
cultureposit
sampl
taken
second
day
fever
mean
day
onset
antibodi
detect
sampl
suggest
infect
cultur
may
neutral
antibodi
dengu
viru
endem
part
indian
ocean
region
resembl
chikv
infect
serum
sampl
receiv
fi
rst
half
includ
patient
travel
diseas
histori
incomplet
test
dengu
viru
patient
dengu
igg
dengu
igm
antibodi
without
igg
found
addit
patient
suggest
acut
infect
patient
travel
mauritiu
one
patient
dengu
igm
chikv
rna
patient
long
period
fever
day
sever
arthralgia
anoth
patient
dengu
igm
antichikv
viru
igm
igg
patient
sever
arthralgia
month
sequenc
pcrposit
sampl
show
origin
genotyp
mutat
island
mauritiu
sampl
fi
rst
half
sampl
india
n
sri
lanka
n
collect
second
half
display
origin
genotyp
chikv
viral
load
among
genotyp
compar
figur
median
concentr
copiesml
copiesml
signifi
cantli
differ
confi
denc
level
exclud
infl
uenc
chikv
antibodi
result
analyz
sampl
without
antibodi
separ
differ
signifi
cant
sampl
n
copiesml
sampl
n
rna
copiesml
chikungunya
fever
becom
major
differenti
diagnosi
along
malaria
dengu
fever
ill
travel
return
europ
indian
ocean
region
chikungunya
fever
similar
symptom
requir
differ
manag
malaria
dengu
laboratori
test
chikv
part
routin
clinic
decis
make
analysi
baselin
virolog
fi
nding
use
modern
repertoir
diagnost
test
compris
largest
cohort
travel
return
site
current
epidem
tourist
particular
interest
seen
context
commun
outbreak
thu
diagnos
need
individu
laboratori
confi
rmation
larg
number
case
studi
enabl
us
establish
gapless
time
cours
virolog
paramet
cumul
singleand
dualpoint
laboratori
determin
individu
infect
travel
crosssect
laboratori
data
provid
good
indic
extent
larg
outbreak
usual
underdiagnos
arboviru
infect
travel
fi
rst
half
much
clinic
suspect
case
chikv
infect
could
confi
rmed
predict
valu
clinic
diagnosi
impress
compar
suspect
dengu
viru
infect
travel
decreas
second
half
probabl
refl
ection
decreas
chikv
activ
tourist
destin
along
shift
indian
subcontin
tourism
less
concentr
cumul
time
cours
antichikv
igg
igm
antibodi
detect
soon
onset
symptom
present
patient
acut
infect
confi
rmed
day
igg
present
earli
addit
test
igm
provid
limit
addit
sensit
detect
acut
case
like
fi
nding
caus
low
sensit
igm
assay
unusu
earli
igg
respons
one
reason
earli
igg
fi
nding
could
lack
specifi
citi
appli
immunofl
uoresc
assay
howev
shown
recent
indirect
immunofl
uoresc
sensit
specifi
c
method
determin
antibodi
chikv
n
litzba
et
al
unpub
data
moreov
confi
rmed
specifi
citi
immunofl
uoresc
assay
result
retest
subset
serum
sampl
plaquereduct
neutral
test
data
shown
antibodyposit
sampl
subject
test
posit
result
final
patient
resid
germani
alphavirus
endem
preexist
antibodi
unlik
must
therefor
assum
igg
result
technic
valid
explan
earli
igg
product
would
presenc
unusu
high
presymptomat
viremia
provid
earli
antigen
stimulu
antibodi
format
cell
cultur
studi
particularli
diagnost
rather
insensit
compar
rtpcr
presenc
antibodi
seem
prevent
isola
tion
viru
success
cultur
cytopath
effect
observ
day
incub
often
requir
least
passag
made
time
cultur
longer
time
seroconvers
nevertheless
cultur
essenti
specifi
c
investig
viru
neutral
test
well
ecolog
basic
research
clinic
viru
detect
rtpcr
seem
method
choic
studi
provid
altern
realtim
rtpcr
protocol
analyt
perform
compar
major
diagnost
pcr
system
protocol
clinic
evalu
whole
cohort
apart
practic
diagnost
implic
fi
nding
identifi
import
question
futur
research
exampl
cours
antibodi
viremia
differ
dengu
viru
infect
probabl
import
differ
earli
igg
respons
chikv
compar
clear
delay
igg
appear
igm
acut
case
primari
dengu
viru
infect
substanti
fraction
patient
dengu
igg
detect
week
ill
one
could
specul
reason
differ
differ
tropism
viru
dengu
viru
infect
predominantli
monocyt
therebi
may
induc
relev
shortterm
immunosuppress
chikv
probabl
share
tropism
although
primari
target
site
chikv
infect
unclear
whether
coinfect
dengu
chikv
would
lead
alter
symptom
anoth
question
patient
studi
coinfect
diseas
cours
may
sever
prolong
patient
detail
control
studi
patient
need
data
viral
load
determin
studi
crucial
infect
control
fi
rst
day
ill
patient
tremend
viru
concentr
sometim
copiesml
plasma
high
viral
load
uncommon
arbovir
diseas
would
make
chikv
prone
nosocomi
transmiss
eg
needlestick
injuri
mucou
membran
exposur
inde
event
alreadi
document
blood
bodi
fl
uid
chikv
patient
consid
infecti
fi
rst
week
symptom
determin
studi
whether
potenti
infect
chikv
may
also
becom
import
context
transfus
analyz
symptomat
patient
howev
viru
concentr
patient
alreadi
decreas
symptom
detect
therefor
high
viremia
presymptomat
patient
seem
like
none
patient
antibodi
day
presymptomat
patient
would
therefor
highli
infecti
issu
transfus
transmiss
chikv
deserv
intens
investig
target
intervent
like
island
blood
donat
suspend
epidem
blood
import
franc
option
india
southeast
asia
larg
epidem
chikv
infect
could
occur
cours
diseas
unusu
sever
unclear
previou
studi
recogn
exchang
envelop
glycoprotein
fi
rst
time
chikv
found
increas
time
isol
island
relat
semliki
forest
viru
correspond
mutat
confer
replic
advantag
cholesteroldeplet
insect
cell
viru
would
implic
advantag
reservoir
addit
fi
nding
schuffeneck
et
al
could
confi
rm
presenc
mutat
mauritiu
larger
part
patient
visit
howev
virus
isol
late
phase
studi
septemb
decemb
patient
return
india
sri
lanka
respect
show
mutat
otherwis
clearli
relat
indian
ocean
strain
signifi
canc
mutat
thu
remain
uncertain
function
studi
need
confi
rmation
genet
connect
would
provid
anoth
exampl
minor
genet
differ
account
major
chang
arthropod
viru
past
ongo
experi
agent
coronaviru
sever
acut
respiratori
syndrom
avian
infl
uenza
virus
chikv
epidem
provid
proof
import
research
ecolog
emerg
reemerg
diseas
dr
pan
physician
medic
virologist
special
emerg
virus
research
focus
develop
molecular
diagnost
assay
patient
care
viru
ecolog
studi
